SCHEMBL4897462

SCHEMBL4897462

CCN(c1ccc(-c2ccc(OC(F)(F)F)cc2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR2 O43614 1/20 0.51
LMNA P02545 2/20 0.47
TRPM8 Q7Z2W7 6/20 0.43
SERPINE1 P05121 3/20 0.43
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43
NR3C1 P04150 1/20 0.42
MAPK1 P28482 1/20 0.42
ESR1 P03372 1/20 0.42
HDAC8 Q9BY41 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
NR1I2 O75469 1/20 0.40
RORA P35398 1/20 0.40
RORC P51449 1/20 0.40
NR1H2 P55055 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904446 0.94 HCRTR2 (0.51) HCRTR2LMNATRPM8SERPINE1GAA
SCHEMBL4903639 0.91 HCRTR2 (0.50) HCRTR2LMNATRPM8SERPINE1GAA
SCHEMBL4906642 0.89 HCRTR2 (0.54) HCRTR2LMNATRPM8SERPINE1GAA
SCHEMBL4897635 0.87 HDAC8 (0.53) LMNASERPINE1MAPK1ESR1HDAC8
SCHEMBL4904184 0.85 HCRTR2 (0.50) HCRTR2LMNATRPM8SERPINE1GAA
SCHEMBL4906301 0.84 HDAC8 (0.51) LMNAMAPK1ESR1HDAC8ALDH1A1
SCHEMBL4906218 0.83 TRPM8 (0.45) TRPM8
SCHEMBL4907142 0.83 HCRTR2 (0.54) HCRTR2LMNATRPM8SERPINE1GAA
SCHEMBL4906264 0.82 LMNA (0.52) LMNANR3C1MAPK1ESR1ALDH1A1
SCHEMBL4904268 0.82 HCRTR2 (0.41) HCRTR2LMNATRPM8MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HCRTR2 3933/4885LMNA 319/4885TRPM8 4317/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HCRTR2 3933/4885LMNA 319/4885TRPM8 4317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.